Literature DB >> 30968460

Cold storage of porcine hepatocyte spheroids for spheroid bioartificial liver.

Yi Li1,2,3, Harvey S Chen2,3, Mohammed Shaheen2,3, Dong Jin Joo2,3, Bruce P Amiot2, Piero Rinaldo4, Scott L Nyberg2,3.   

Abstract

BACKGROUND AND AIMS: Cell-based therapies for liver disease such as bioartificial liver rely on a large quantity and high quality of hepatocytes. Cold storage was previously shown to be a better way to preserve the viability and functionality of hepatocytes during transportation rather than freezing, but this was only proved at a lower density of rat hepatocytes spheroids. The purpose of this study was to optimize conditions for cold storage of high density of primary porcine hepatocyte spheroids.
METHODS: Porcine hepatocytes were isolated by a three-step perfusion method; hepatocyte spheroids were formed by a 24 hours rocked culture technique. Hepatocyte cell density was 5 × 106 /mL in 1000 mL spheroid forming medium. Spheroids were then maintained in rocked culture at 37°C (control condition) or cold stored at 4°C for 24, 48 or 72 hours in four different cold storage solutions: histidine-tryptophan-ketoglutarate (HTK) alone; HTK + 1 mM deferoxamine (DEF); HTK + 5 mM N-acetyl-L-cysteine (NAC); and HTK + 1 mM DEF + 5 mM NAC. The viability, ammonia clearance, albumin production, gene expression, and functional activity of cytochrome P450 enzymes were measured after recovery from the cold storage.
RESULTS: In this study, we observed that cold-induced injury was reduced by the addition of the iron chelator. Viability of HTK + DEF group hepatocyte spheroids was increased compared with other cold storage groups (P < 0.05). Performance metrics of porcine hepatocyte spheroids cold stored for 24 hours were similar to those in control conditions. The hepatocyte spheroids in control conditions started to lose their ability to clear ammonia while production of albumin was still active at 48 and 72 hours (P < 0.05). In contrast, the viability and functionality of hepatocyte spheroids including ammonia clearance and albumin secretion were preserved in HTK + DEF group at both 48- and 72-hour time points (P < 0.05).
CONCLUSIONS: The beneficial effects of HTK supplemented with DEF were more obvious after cold storage of high density of porcine hepatocyte spheroids for 72 hours. The porcine hepatocyte spheroids were above the cutoff criteria for use in a spheroid-based bioartificial liver.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cold storage; hepatocyte; porcine; spheroid

Year:  2019        PMID: 30968460      PMCID: PMC6717030          DOI: 10.1111/xen.12512

Source DB:  PubMed          Journal:  Xenotransplantation        ISSN: 0908-665X            Impact factor:   3.907


  27 in total

1.  New concepts in liver regeneration.

Authors:  Kimberly J Riehle; Yock Y Dan; Jean S Campbell; Nelson Fausto
Journal:  J Gastroenterol Hepatol       Date:  2011-01       Impact factor: 4.029

Review 2.  The current status of primary hepatocyte culture.

Authors:  T Mitaka
Journal:  Int J Exp Pathol       Date:  1998-12       Impact factor: 1.925

3.  Reply to: "Pivotal preclinical trial of the spheroid reservoir bioartificial liver".

Authors:  Jaime M Glorioso; Shennen A Mao; Brian Rodysill; Taufic Mounajjed; Walter K Kremers; Faysal Elgilani; Raymond D Hickey; Hakon Haugaa; Christopher F Rose; Bruce Amiot; Scott L Nyberg
Journal:  J Hepatol       Date:  2015-07-02       Impact factor: 25.083

4.  Randomized Trial of Spheroid Reservoir Bioartificial Liver in Porcine Model of Posthepatectomy Liver Failure.

Authors:  Harvey S Chen; Dong Jin Joo; Mohammed Shaheen; Yi Li; Yujia Wang; Jian Yang; Clara T Nicolas; Kelly Predmore; Bruce Amiot; Gregory Michalak; Taofic Mounajjed; Jeff Fidler; Walter K Kremers; Scott L Nyberg
Journal:  Hepatology       Date:  2018-12-27       Impact factor: 17.425

5.  N-acetylcysteine improves the viability of human hepatocytes isolated from severely steatotic donor liver tissue.

Authors:  Filippos G Sagias; Ragai R Mitry; Robin D Hughes; Sharon C Lehec; Ameet G Patel; Mohamed Rela; Giorgina Mieli-Vergani; Nigel D Heaton; Anil Dhawan
Journal:  Cell Transplant       Date:  2010-06-29       Impact factor: 4.064

6.  Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure.

Authors:  Achilles A Demetriou; Robert S Brown; Ronald W Busuttil; Jeffrey Fair; Brendan M McGuire; Philip Rosenthal; Jan Schulte Am Esch; Jan Lerut; Scott L Nyberg; Mauro Salizzoni; Elizabeth A Fagan; Bernard de Hemptinne; Christoph E Broelsch; Maurizio Muraca; Joan Manuel Salmeron; John M Rabkin; Herold J Metselaar; Daniel Pratt; Manuel De La Mata; Lawrence P McChesney; Gregory T Everson; Philip T Lavin; Anthony C Stevens; Zorina Pitkin; Barry A Solomon
Journal:  Ann Surg       Date:  2004-05       Impact factor: 12.969

7.  Iron-dependent vs. iron-independent cold-induced injury to cultured rat hepatocytes: a comparative study in physiological media and organ preservation solutions.

Authors:  Ursula Rauen; Uta Kerkweg; Herbert de Groot
Journal:  Cryobiology       Date:  2006-12-24       Impact factor: 2.487

8.  Disruption of epithelial cell-matrix interactions induces apoptosis.

Authors:  S M Frisch; H Francis
Journal:  J Cell Biol       Date:  1994-02       Impact factor: 10.539

9.  N-acetylcysteine attenuates ischemia-reperfusion-induced apoptosis and autophagy in mouse liver via regulation of the ROS/JNK/Bcl-2 pathway.

Authors:  Chengfen Wang; Kan Chen; Yujing Xia; Weiqi Dai; Fan Wang; Miao Shen; Ping Cheng; Junshan Wang; Jie Lu; Yan Zhang; Jing Yang; Rong Zhu; Huawei Zhang; Jingjing Li; Yuanyuan Zheng; Yingqun Zhou; Chuanyong Guo
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

10.  Spheroidal aggregate culture of rat liver cells: histotypic reorganization, biomatrix deposition, and maintenance of functional activities.

Authors:  J Landry; D Bernier; C Ouellet; R Goyette; N Marceau
Journal:  J Cell Biol       Date:  1985-09       Impact factor: 10.539

View more
  1 in total

Review 1.  Current status of xenotransplantation research and the strategies for preventing xenograft rejection.

Authors:  Qiao Zhou; Ting Li; Kaiwen Wang; Qi Zhang; Zhuowen Geng; Shaoping Deng; Chunming Cheng; Yi Wang
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.